Cargando…

Disruption of a GATA4/Ankrd1 Signaling Axis in Cardiomyocytes Leads to Sarcomere Disarray: Implications for Anthracycline Cardiomyopathy

Doxorubicin (Adriamycin) is an effective anti-cancer drug, but its clinical usage is limited by a dose-dependent cardiotoxicity characterized by widespread sarcomere disarray and loss of myofilaments. Cardiac ankyrin repeat protein (CARP, ANKRD1) is a transcriptional regulatory protein that is extre...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Billy, Zhong, Lin, Roush, Sarah F., Pentassuglia, Laura, Peng, Xuyang, Samaras, Susan, Davidson, Jeffrey M., Sawyer, Douglas B., Lim, Chee Chew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3332030/
https://www.ncbi.nlm.nih.gov/pubmed/22532871
http://dx.doi.org/10.1371/journal.pone.0035743
_version_ 1782230170216693760
author Chen, Billy
Zhong, Lin
Roush, Sarah F.
Pentassuglia, Laura
Peng, Xuyang
Samaras, Susan
Davidson, Jeffrey M.
Sawyer, Douglas B.
Lim, Chee Chew
author_facet Chen, Billy
Zhong, Lin
Roush, Sarah F.
Pentassuglia, Laura
Peng, Xuyang
Samaras, Susan
Davidson, Jeffrey M.
Sawyer, Douglas B.
Lim, Chee Chew
author_sort Chen, Billy
collection PubMed
description Doxorubicin (Adriamycin) is an effective anti-cancer drug, but its clinical usage is limited by a dose-dependent cardiotoxicity characterized by widespread sarcomere disarray and loss of myofilaments. Cardiac ankyrin repeat protein (CARP, ANKRD1) is a transcriptional regulatory protein that is extremely susceptible to doxorubicin; however, the mechanism(s) of doxorubicin-induced CARP depletion and its specific role in cardiomyocytes have not been completely defined. We report that doxorubicin treatment in cardiomyocytes resulted in inhibition of CARP transcription, depletion of CARP protein levels, inhibition of myofilament gene transcription, and marked sarcomere disarray. Knockdown of CARP with small interfering RNA (siRNA) similarly inhibited myofilament gene transcription and disrupted cardiomyocyte sarcomere structure. Adenoviral overexpression of CARP, however, was unable to rescue the doxorubicin-induced sarcomere disarray phenotype. Doxorubicin also induced depletion of the cardiac transcription factor GATA4 in cardiomyocytes. CARP expression is regulated in part by GATA4, prompting us to examine the relationship between GATA4 and CARP in cardiomyocytes. We show in co-transfection experiments that GATA4 operates upstream of CARP by activating the proximal CARP promoter. GATA4-siRNA knockdown in cardiomyocytes inhibited CARP expression and myofilament gene transcription, and induced extensive sarcomere disarray. Adenoviral overexpression of GATA4 (AdV-GATA4) in cardiomyocytes prior to doxorubicin exposure maintained GATA4 levels, modestly restored CARP levels, and attenuated sarcomere disarray. Interestingly, siRNA-mediated depletion of CARP completely abolished the Adv-GATA4 rescue of the doxorubicin-induced sarcomere phenotype. These data demonstrate co-dependent roles for GATA4 and CARP in regulating sarcomere gene expression and maintaining sarcomeric organization in cardiomyocytes in culture. The data further suggests that concurrent depletion of GATA4 and CARP in cardiomyocytes by doxorubicin contributes in large part to myofibrillar disarray and the overall pathophysiology of anthracycline cardiomyopathy.
format Online
Article
Text
id pubmed-3332030
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-33320302012-04-24 Disruption of a GATA4/Ankrd1 Signaling Axis in Cardiomyocytes Leads to Sarcomere Disarray: Implications for Anthracycline Cardiomyopathy Chen, Billy Zhong, Lin Roush, Sarah F. Pentassuglia, Laura Peng, Xuyang Samaras, Susan Davidson, Jeffrey M. Sawyer, Douglas B. Lim, Chee Chew PLoS One Research Article Doxorubicin (Adriamycin) is an effective anti-cancer drug, but its clinical usage is limited by a dose-dependent cardiotoxicity characterized by widespread sarcomere disarray and loss of myofilaments. Cardiac ankyrin repeat protein (CARP, ANKRD1) is a transcriptional regulatory protein that is extremely susceptible to doxorubicin; however, the mechanism(s) of doxorubicin-induced CARP depletion and its specific role in cardiomyocytes have not been completely defined. We report that doxorubicin treatment in cardiomyocytes resulted in inhibition of CARP transcription, depletion of CARP protein levels, inhibition of myofilament gene transcription, and marked sarcomere disarray. Knockdown of CARP with small interfering RNA (siRNA) similarly inhibited myofilament gene transcription and disrupted cardiomyocyte sarcomere structure. Adenoviral overexpression of CARP, however, was unable to rescue the doxorubicin-induced sarcomere disarray phenotype. Doxorubicin also induced depletion of the cardiac transcription factor GATA4 in cardiomyocytes. CARP expression is regulated in part by GATA4, prompting us to examine the relationship between GATA4 and CARP in cardiomyocytes. We show in co-transfection experiments that GATA4 operates upstream of CARP by activating the proximal CARP promoter. GATA4-siRNA knockdown in cardiomyocytes inhibited CARP expression and myofilament gene transcription, and induced extensive sarcomere disarray. Adenoviral overexpression of GATA4 (AdV-GATA4) in cardiomyocytes prior to doxorubicin exposure maintained GATA4 levels, modestly restored CARP levels, and attenuated sarcomere disarray. Interestingly, siRNA-mediated depletion of CARP completely abolished the Adv-GATA4 rescue of the doxorubicin-induced sarcomere phenotype. These data demonstrate co-dependent roles for GATA4 and CARP in regulating sarcomere gene expression and maintaining sarcomeric organization in cardiomyocytes in culture. The data further suggests that concurrent depletion of GATA4 and CARP in cardiomyocytes by doxorubicin contributes in large part to myofibrillar disarray and the overall pathophysiology of anthracycline cardiomyopathy. Public Library of Science 2012-04-20 /pmc/articles/PMC3332030/ /pubmed/22532871 http://dx.doi.org/10.1371/journal.pone.0035743 Text en Chen et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Chen, Billy
Zhong, Lin
Roush, Sarah F.
Pentassuglia, Laura
Peng, Xuyang
Samaras, Susan
Davidson, Jeffrey M.
Sawyer, Douglas B.
Lim, Chee Chew
Disruption of a GATA4/Ankrd1 Signaling Axis in Cardiomyocytes Leads to Sarcomere Disarray: Implications for Anthracycline Cardiomyopathy
title Disruption of a GATA4/Ankrd1 Signaling Axis in Cardiomyocytes Leads to Sarcomere Disarray: Implications for Anthracycline Cardiomyopathy
title_full Disruption of a GATA4/Ankrd1 Signaling Axis in Cardiomyocytes Leads to Sarcomere Disarray: Implications for Anthracycline Cardiomyopathy
title_fullStr Disruption of a GATA4/Ankrd1 Signaling Axis in Cardiomyocytes Leads to Sarcomere Disarray: Implications for Anthracycline Cardiomyopathy
title_full_unstemmed Disruption of a GATA4/Ankrd1 Signaling Axis in Cardiomyocytes Leads to Sarcomere Disarray: Implications for Anthracycline Cardiomyopathy
title_short Disruption of a GATA4/Ankrd1 Signaling Axis in Cardiomyocytes Leads to Sarcomere Disarray: Implications for Anthracycline Cardiomyopathy
title_sort disruption of a gata4/ankrd1 signaling axis in cardiomyocytes leads to sarcomere disarray: implications for anthracycline cardiomyopathy
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3332030/
https://www.ncbi.nlm.nih.gov/pubmed/22532871
http://dx.doi.org/10.1371/journal.pone.0035743
work_keys_str_mv AT chenbilly disruptionofagata4ankrd1signalingaxisincardiomyocytesleadstosarcomeredisarrayimplicationsforanthracyclinecardiomyopathy
AT zhonglin disruptionofagata4ankrd1signalingaxisincardiomyocytesleadstosarcomeredisarrayimplicationsforanthracyclinecardiomyopathy
AT roushsarahf disruptionofagata4ankrd1signalingaxisincardiomyocytesleadstosarcomeredisarrayimplicationsforanthracyclinecardiomyopathy
AT pentassuglialaura disruptionofagata4ankrd1signalingaxisincardiomyocytesleadstosarcomeredisarrayimplicationsforanthracyclinecardiomyopathy
AT pengxuyang disruptionofagata4ankrd1signalingaxisincardiomyocytesleadstosarcomeredisarrayimplicationsforanthracyclinecardiomyopathy
AT samarassusan disruptionofagata4ankrd1signalingaxisincardiomyocytesleadstosarcomeredisarrayimplicationsforanthracyclinecardiomyopathy
AT davidsonjeffreym disruptionofagata4ankrd1signalingaxisincardiomyocytesleadstosarcomeredisarrayimplicationsforanthracyclinecardiomyopathy
AT sawyerdouglasb disruptionofagata4ankrd1signalingaxisincardiomyocytesleadstosarcomeredisarrayimplicationsforanthracyclinecardiomyopathy
AT limcheechew disruptionofagata4ankrd1signalingaxisincardiomyocytesleadstosarcomeredisarrayimplicationsforanthracyclinecardiomyopathy